DBMYX
Price
$22.44
Change
-$0.46 (-2.01%)
Updated
Dec 12 closing price
Net Assets
893.82M
PMBCX
Price
$33.11
Change
-$0.16 (-0.48%)
Updated
Dec 12 closing price
Net Assets
29.83B
Interact to see
Advertisement

DBMYX vs PMBCX

Header iconDBMYX vs PMBCX Comparison
Open Charts DBMYX vs PMBCXBanner chart's image
BNY Mellon Sm/Md Cp Gr Y
Price$22.44
Change-$0.46 (-2.01%)
VolumeN/A
Net Assets893.82M
Principal MidCap C
Price$33.11
Change-$0.16 (-0.48%)
VolumeN/A
Net Assets29.83B
DBMYX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
DBMYX vs. PMBCX commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMYX is a StrongBuy and PMBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 29.8B vs. DBMYX (894M). DBMYX (0.00) and PMBCX (0.00) have matching dividends . DBMYX was incepted earlier than PMBCX: DBMYX (12 years) vs PMBCX (19 years). PMBCX (1.75) is less costly to investors than DBMYX (0.67). DBMYX is a more actively managed with annual turnover of: 48.92 vs. PMBCX (10.50). PMBCX has a lower initial minimum investment than DBMYX: PMBCX (1000) vs DBMYX (1000000). PMBCX annual gain was more profitable for investors over the last year : -13.58 vs. DBMYX (-26.15). PMBCX return over 5 years is better than : 11.31 vs. DBMYX (-39.50).
DBMYXPMBCXDBMYX / PMBCX
Total Expense Ratio0.621.7535%
Annual Report Gross Expense Ratio0.671.7538%
Fund Existence12 years19 years-
Gain YTD-21.575-5.214414%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets894M29.8B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year-26.15-13.58193%
Returns for 3 years-3.0921.69-14%
Returns for 5 years-39.5011.31-349%
Returns for 10 years46.7966.1071%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY1.000.01
+0.89%
Oncolytics Biotech
FDMT10.920.09
+0.83%
4D Molecular Therapeutics
HAFN5.680.02
+0.35%
Hafnia Limited
Z75.780.25
+0.33%
Zillow Group
MIGI6.10-0.60
-8.96%
Mawson Infrastructure Group Inc.